IL-6: Not associated with ↑ risk of VTE in oncologic patients;IL-6: ↑ risk of mortality during the first year after VTE [53];IL-6: ↑ risk of DVT recurrence, PTS and CTEPH [88,89,90];IL-8: ↑ risk of VTE recurrence [90];IL-10: protective factor for VTE [85];Lower levels of IL-10: ↑ risk of VTE and VTE recurrence [78,86]. Here, CXCL8 is linked to deep vein thrombosis.